Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference.

Presentation Details:

Date: October 6, 2022
Time: 12:00 p.m. (ET)
Location: The Yale Club, New York City, New York

https://www.roth.com/conferences/upcoming-conferences

About Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar’s pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19; and an early-stage camsirubicin analog, MNPR-202, for various cancers. For more information, visit: www.monopartx.com.

CONTACT:  

Monopar Therapeutics Inc.
Investor Relations  
Kim R. Tsuchimoto  
Chief Financial Officer  
kimtsu@monopartx.com

Follow Monopar on social media for updates: 
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

 

Staff

Recent Posts

Talkdesk AI Agents for voice powers human-like conversational virtual agents that operate, understand, respond, and take action autonomously, revolutionizing customer engagement

The Talkdesk Ascend AI platform, through agentic artificial intelligence, gives companies access to advanced multi-channel…

5 hours ago

Health in Tech Expands Executive Team to Drive Growth and Innovation

Dustin Plantholt appointed Chief Growth OfficerChris Kurtenbach appointed Chief Operating Officer(Jonathan) Del Lockett appointed Chief…

5 hours ago

Fathom Holdings Appoints Highly Experienced Technology Industry Expert Adam Rothstein to Board of Directors

CARY, N.C., March 17, 2025 /PRNewswire/ -- Fathom Holdings, Inc. (Nasdaq: FTHM) ("Fathom"; or the…

5 hours ago

Wonderfeel Partners with Truemed to Make Science-Backed Longevity Products HSA/FSA Eligible

SAN FRANCISCO, March 18, 2025 /PRNewswire/ -- Wonderfeel Biosciences, an industry leader in revolutionary longevity technologies,…

5 hours ago

TiE South Coast Announces The Inaugural AI2025 Innovation Awards

Recipients Personify Excellence in AI, Real-Life Leadership, and Impact across the Greater San Diego Region Winners…

5 hours ago

PrimeRx Wins at the 2025 Stevie Awards for Customer Center Excellence for Second Consecutive Year

UNIONDALE, N.Y., March 17, 2025 /PRNewswire/ -- PrimeRx, a leading provider of pharmacy management technology,…

5 hours ago